Remap Consulting is a specialist pharmaceutical pricing and market access consultancy
We work with people responsible for the pricing and reimbursement of products who are asking:
What is the optimal price for our product?
Have we got the right evidence to support pricing and market access at launch?
Do we have the right training capabilities in house to secure pricing and reimbursement?
What is the pricing and market access potential for our business development opportunities?
Launch
Implementation
Price & Market Access Training
Price
Optimization
Our mission is to support you in solving your pricing and market access challenges to improve patient access to your products
This has been an excellent two days. You have truly been a pleasure to work with, bringing great learning techniques as well as pricing and market access insights.
Excellent work. The project ran very smoothly and we appreciated your efficient approach to managing the project and delivery of final recommendations.
Latest News
Empowering patient involvement in HTA through effective education: the impact of EUPATI
The movement towards increasing patient involvement in HTA Historically, patient involvement in health technology assessment (HTA) processes and decision-making has [...]
A single, mandatory HTA assessment for Europe by 2026? The European commission gets serious about EU HTA cooperation.
Over the last year, the European Commission (EC) has been consulting on multiple scenarios for HTA harmonisation, as we discussed [...]
The arrival of gene therapies: how can payers and pharma address the budget impact problem?
A potential cure, but at what price? The development of gene therapies represents a new frontier of science, with the [...]
The results of our market access training survey are in!
Over the last 3 months, we have been conducting a survey to understand how pricing and market access is regarded [...]